Advertisement

Topics

Sanpower Group Closes Acquisition of Dendreon

07:21 EDT 29 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
– Company to Focus on Accelerating Its Positive Growth Trajectory for PROVENGE and Expanding Clinical Development Program – – James Caggiano Promoted to Chief Executive Officer of Dendreon – Dendreon Pharmac...

Other Sources for this Article

For Dendreon Pharmaceuticals LLC
Leslie Bryant, +1 562-505-9290
lbryant@w2ogroup.com
or
Sanpower Group
Jeffrey Jing
jingtian@sanpowergroup.com
or
Jason Ji
jiliang@sanpowergroup.com

NEXT ARTICLE

More From BioPortfolio on "Sanpower Group Closes Acquisition of Dendreon"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...